A Randomized, Sham-controlled Trial: Endoscopic Myotomy of the Pylorus to Improve Emptying and Symptoms (EMPTIES)

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

A randomized clinical trial comparing endoscopic per-oral pyloromyotomy (POP) versus a control sham intervention (diagnostic esophagogastroduodenoscopy (EGD) without pyloric disruption) in patients with medically refractory gastroparesis.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Male or female, aged 18-75

• Diagnosis of medically refractory gastroparesis by 4 hour non-extrapolated solid phase gastric emptying study completed within 12 months of enrollment. Medical refractoriness is defined by at least 6 months of medical treatment with no significant improvement in baseline symptoms

• Completion of all routine assessments in our multidisciplinary gastroparesis clinic, which includes evaluation by gastroenterology, behavioral health, and nutrition specialists

• Ability to take oral medication and be willing to adhere to the post-procedure dietary and medication regimen

• For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation

• Stated willingness to comply with all study procedures and availability for the duration of the study

• Willingness and reasonable expectation that the individual will be able to travel to the study site for the intervention and each scheduled in-person assessment, as well as virtual assessments if necessary

• Be able to speak and read the English language.

Locations
United States
Ohio
Cleveland Clinic Foundation
RECRUITING
Cleveland
Contact Information
Primary
Karim Kheniser
khenisk@ccf.org
2164449941
Time Frame
Start Date: 2022-02-23
Estimated Completion Date: 2026-07
Participants
Target number of participants: 100
Treatments
Active_comparator: Endoscopic per-oral pyloromyotomy (POP)
Participants will undergo Endoscopic per-oral pyloromyotomy (POP).
Sham_comparator: Sham / Control Arm
Participants will undergo a diagnostic esophagogastroduodenoscopy (EGD) without pyloric disruption. Following the 12-week blinded trial period, these participants will be unblinded and offered Endoscopic per-oral pyloromyotomy (POP) if they remain symptomatic.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Leads: Matthew Allemang

This content was sourced from clinicaltrials.gov